Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Device Industry Grab-Bag Of Provisions In 21st Century Cures Draft

This article was originally published in The Gray Sheet

Executive Summary

Device industry advocates have a lot of reading to do. There are more than two dozen provisions with relevance to the medtech sector, many aimed at smoothing the way for product approvals and reimbursement, in a 21st Century Cures discussion draft unveiled by the House Energy and Commerce panel Jan. 27. The initial proposal does not have bipartisan support.

Advertisement

Related Content

Combo Products GMP Guidance Fills In Gaps On Drug-Delivery Device Compliance
IRB, HIPAA Changes To Be Folded Into 21st Century Cures Bill Next Year
FDA’s Expedited PMA Pathway Proposal: To Expand Or Contain?
AIM Act Touted As One Solution To Device Reimbursement Woes
Leap Ahead With EAP? FDA Proposes New Expedited PMA Pathway

Topics

Advertisement
UsernamePublicRestriction

Register

MT034440

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel